Ethos Financial Group, LLC
Position in NWBO — Northwest Biotherapeutics Inc
CIK 1954242
KING OF PRUSSIA, PA
Position in NWBO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,423
-$781 QoQ
Shares Held
39,070
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 8 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NWBO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ethos Financial Group, LLC holds $1,531,772 across 7 Biotechnology names. NWBO ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
20,157 | $786,324 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
464 | $230,482 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
731 | $220,052 | |
| 4 | SLS |
SELLAS Life Sciences Group, Inc.
|
10,000 | $147,600 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
20,398 | $74,860 | |
| 6 | NRXP |
NRX Pharmaceuticals, Inc.
|
15,900 | $65,031 | |
| 7 | NWBO |
Northwest Biotherapeutics Inc
This page
|
39,070 | $7,423 |
All Filings in NWBO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,423 | 39,070 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $8,204 | 39,070 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $6,520 | 28,350 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $6,084 | 25,350 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $11,772 | 49,050 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $5,451 | 23,700 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,399 | 23,700 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $7,584 | 23,700 | Shares | Sole | 2024-11-07 | |
| 2024-03-31 | $12,324 | 23,700 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||